Cargando…
Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, idiosyncratic reaction to a drug which presents after a prolonged latency period. Although it most commonly occurs with aromatic anticonvulsants, antibiotics are also occasionally implicated. A 50-year-old male was a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196285/ https://www.ncbi.nlm.nih.gov/pubmed/35466662 http://dx.doi.org/10.4103/jpgm.JPGM_1226_20 |
_version_ | 1784727152379297792 |
---|---|
author | Bai, M Govindaraj, V Kottaisamy, R Vijayarangam, N |
author_facet | Bai, M Govindaraj, V Kottaisamy, R Vijayarangam, N |
author_sort | Bai, M |
collection | PubMed |
description | Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, idiosyncratic reaction to a drug which presents after a prolonged latency period. Although it most commonly occurs with aromatic anticonvulsants, antibiotics are also occasionally implicated. A 50-year-old male was admitted for left pyopneumothorax. He was started on intravenous piperacillin-tazobactam (Pip/Taz) and clindamycin. After 10 days of treatment, he developed high grade fever with maculopapular rashes with areas of scaling. He had elevated WBC counts with eosinophils of 21% and raised serum transaminases. After excluding other possible etiologies for febrile illness, a possibility of DRESS was considered. Naranjo scale, used for causality assessment, yielded a total score of 6, pointing toward probable adverse drug reaction. Also, the patient had 6 out of the 7 inclusion criteria for DRESS as per European Registry of Severe Cutaneous Adverse Reaction (RegiScar) scoring. Pip/Taz was found to be causative drug and was discontinued. He was conservatively managed with antipyretics and topical steroids. Fever subsided the day after stopping Pip/Taz and his rashes resolved gradually. In conclusion the possibility of antibiotics-induced DRESS should be considered and high index of vigilance is advised. |
format | Online Article Text |
id | pubmed-9196285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-91962852022-06-15 Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use Bai, M Govindaraj, V Kottaisamy, R Vijayarangam, N J Postgrad Med ADR Report Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, idiosyncratic reaction to a drug which presents after a prolonged latency period. Although it most commonly occurs with aromatic anticonvulsants, antibiotics are also occasionally implicated. A 50-year-old male was admitted for left pyopneumothorax. He was started on intravenous piperacillin-tazobactam (Pip/Taz) and clindamycin. After 10 days of treatment, he developed high grade fever with maculopapular rashes with areas of scaling. He had elevated WBC counts with eosinophils of 21% and raised serum transaminases. After excluding other possible etiologies for febrile illness, a possibility of DRESS was considered. Naranjo scale, used for causality assessment, yielded a total score of 6, pointing toward probable adverse drug reaction. Also, the patient had 6 out of the 7 inclusion criteria for DRESS as per European Registry of Severe Cutaneous Adverse Reaction (RegiScar) scoring. Pip/Taz was found to be causative drug and was discontinued. He was conservatively managed with antipyretics and topical steroids. Fever subsided the day after stopping Pip/Taz and his rashes resolved gradually. In conclusion the possibility of antibiotics-induced DRESS should be considered and high index of vigilance is advised. Wolters Kluwer - Medknow 2022 2022-04-20 /pmc/articles/PMC9196285/ /pubmed/35466662 http://dx.doi.org/10.4103/jpgm.JPGM_1226_20 Text en Copyright: © 2022 Journal of Postgraduate Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | ADR Report Bai, M Govindaraj, V Kottaisamy, R Vijayarangam, N Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use |
title | Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use |
title_full | Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use |
title_fullStr | Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use |
title_full_unstemmed | Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use |
title_short | Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use |
title_sort | drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use |
topic | ADR Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196285/ https://www.ncbi.nlm.nih.gov/pubmed/35466662 http://dx.doi.org/10.4103/jpgm.JPGM_1226_20 |
work_keys_str_mv | AT baim drugreactionwitheosinophiliaandsystemicsymptomssyndromerelatedtopiperacillintazobactamuse AT govindarajv drugreactionwitheosinophiliaandsystemicsymptomssyndromerelatedtopiperacillintazobactamuse AT kottaisamyr drugreactionwitheosinophiliaandsystemicsymptomssyndromerelatedtopiperacillintazobactamuse AT vijayarangamn drugreactionwitheosinophiliaandsystemicsymptomssyndromerelatedtopiperacillintazobactamuse |